SUN PHARMACEUTICAL IND LViés de alta
Long
The stock is approximately 56.9% undervalued relative to its intrinsic value of 4,137.50, suggesting a significant buying opportunity at the current price of 1,783.
Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
DO WHAT OTHERS DON"T KNOW AND DON'T DO WHAT OTHERS KNOW
DO WHAT OTHERS DON"T KNOW AND DON'T DO WHAT OTHERS KNOW
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.